Target intelligence / Profile preview

U6 small nuclear RNA 9 (RNU6-9)

Target
RNU6-9
Molecular classification
Small nuclear RNA (snRNA), Non-coding RNA
01

Overview

U6 small nuclear RNA 9 (RNU6-9) encodes a variant of U6 snRNA, a non-coding RNA critical for the function of the spliceosome—the molecular machine responsible for removing introns from precursor messenger RNA in eukaryotic cells[5][1][3]. U6 snRNA is highly conserved and present in multiple gene copies in vertebrates; RNU6-9 is one such copy[1]. U6 snRNA, together with U1, U2, U4, and U5 snRNAs, and numerous proteins, forms small nuclear ribonucleoproteins (snRNPs) that catalyze the two transesterification steps of splicing[5]. U6 snRNA directly participates at the catalytic core of the spliceosome, binding with other snRNAs and proteins, and base pairing to intron splice sites[5][1]. While dysregulation of U6 snRNA has been observed in disease models, particularly infectious or cancerous states, it is not a classical drug target nor is its modulation currently used clinically[4][5].

Other names
U6 Small Nuclear 9RNU6-9U6-9
02

Biological functions

Pre-mRNA splicing via the spliceosome[5][1]Formation of the spliceosomal catalytic core[1][5]RNA-protein complex assembly (snRNP)[3]
03

Disease associations

Other (altered U6 snRNA levels may influence gene expression patterns during cellular stress, viral infection, or cancer through dysregulation of splicing[4])

Beyond the preview

Go deeper on U6 small nuclear RNA 9 (RNU6-9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 9 (RNU6-9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call